Avantax Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Buy |
+2,498
| New | +$314K | ﹤0.01% | 1875 |
|
|
2024
Q3 | – | Sell |
-1,117
| Closed | -$259K | – | 2129 |
|
|
2024
Q2 | $259K | Buy |
+1,117
| New | +$259K | ﹤0.01% | 1796 |
|
|
2023
Q4 | – | Sell |
-833
| Closed | -$214K | – | 1580 |
|
|
2023
Q3 | $214K | Sell |
833
-13
| -2% | -$3.34K | ﹤0.01% | 1391 |
|
|
2023
Q2 | $241K | Sell |
846
-43
| -5% | -$12.3K | ﹤0.01% | 1303 |
|
|
2023
Q1 | $247K | Sell |
889
-31
| -3% | -$8.62K | ﹤0.01% | 1255 |
|
|
2022
Q4 | $255K | Buy |
920
+19
| +2% | +$5.26K | ﹤0.01% | 1189 |
|
|
2022
Q3 | $241K | Buy |
+901
| New | +$241K | ﹤0.01% | 1112 |
|
|
2022
Q2 | – | Sell |
-1,127
| Closed | -$236K | – | 1313 |
|
|
2022
Q1 | $236K | Sell |
1,127
-36
| -3% | -$7.54K | ﹤0.01% | 1118 |
|
|
2021
Q4 | $279K | Sell |
1,163
-1,012
| -47% | -$243K | ﹤0.01% | 1011 |
|
|
2021
Q3 | $617K | Buy |
2,175
+648
| +42% | +$184K | 0.01% | 637 |
|
|
2021
Q2 | $528K | Buy |
+1,527
| New | +$528K | 0.01% | 693 |
|
|
2020
Q4 | – | Sell |
-1,753
| Closed | -$497K | – | 970 |
|
|
2020
Q3 | $497K | Buy |
+1,753
| New | +$497K | 0.01% | 784 |
|
|
2020
Q2 | – | Sell |
-830
| Closed | -$264K | – | 854 |
|
|
2020
Q1 | $264K | Buy |
+830
| New | +$264K | 0.01% | 625 |
|